For a second year, ISPE and FDA have collaborated to create a joint conference focused on the future vision of the pharmaceutical industry and the importance of driving a culture of quality throughout companies and regulatory agencies.
The event will assemble the entire supply chain to discuss industry’s commitment to identifying and adopting quality practices that continue to deliver a safe, consistent and available global drug supply.
Expert speakers and solution-focused sessions will discuss quality and manufacturing challenges, as well as provide attendees with new insights and executable action plans.
Gain an understanding of how to build and sustain a quality culture so your organization
• Improve Process • Minimize Risk • Decrease Cost • Increase Flexibility • Remain Compliant
Quality Metrics Session - Participate in discussions aimed at advancing industry-wide change. Gain insight into FDA's planned direction, challenges to alignment across industry and a recommended path forward.
Val Jensen, Associate Director for Drug Shortage, CDER, FDA confirmed to present Consequences of Drug Shortages
ISPE confirms 15 participating regulators
Be among the first to hear results of ISPE’s Drug Shortage Survey!
Plenary Speakers: Howard Sklamberg, J.D., Andy Skibo, Gerald Heddell, John Pinion and Jaspreet Gill
The Chesapeake Bay Area Chapter presents their 2013 Summer Social: Orioles Game on 13 June!